- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Papulopustular Rosacea
Total 649 results
-
PfizerTerminatedModerate-severe PainUnited States
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingModerate to Severe AsthmaUnited States
-
Fresenius Kabi SwissBioSim GmbHCompletedModerate to Severe Rheumatoid ArthritisBulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
University of PadovaUnknownModerate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Italy
-
PfizerTerminatedModerate-severe PainUnited States
-
Ulthera, IncUniversity of Texas Southwestern Medical CenterCompletedMild to Moderate Skin Laxity on Cheek | Mild to Moderate Skin Laxity on Upper Neck | Mild to Moderate Subcutaneous Fat on Cheek | Mild to Moderate Subcutaneous Fat on Upper Neck
-
ImmuneMed, Inc.Not yet recruitingModerate to Severe Rheumatoid ArthritisNetherlands
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
Bracco Diagnostics, IncCompleted
-
Helsinn Healthcare SACelerionCompletedHealthy Volunteers | Non-smokers | Moderate to Heavy SmokersUnited States
-
AstraZenecaRecruitingModerate-to-Severe AsthmaChina
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women's Hospital and other collaboratorsRecruitingModerate to Severe AsthmaUnited States
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
AbbVie (prior sponsor, Abbott)University Health Network, TorontoCompletedModerate-to-severe Rheumatoid Arthritis
-
The First Affiliated Hospital with Nanjing Medical...RecruitingModerate to Severe Allergic AsthmaChina
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
Raphaelle Jaquet-PilloudSwiss Foundation for the Health of Children and AdolescentsCompletedModerate to Severe BronchiolitisSwitzerland
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
Zhejiang Hisun Pharmaceutical Co. Ltd.CompletedModerate to Severe Active Rheumatoid ArthritisChina
-
Cytos Biotechnology AGTerminatedModerate to Severe Allergic AsthmaUnited States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
Synta Pharmaceuticals Corp.CompletedActive, Moderate to Severe Rheumatoid ArthritisNetherlands
-
United States Army Research Institute of Environmental...CompletedResponse to Severe StressUnited States
-
Incyte CorporationWithdrawnModerate to Severe Ulcerative Colitis
-
San Diego Veterans Healthcare SystemCongressionally Directed Medical Research ProgramsCompletedPTSD With a History of Mild to Moderate TBIUnited States
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
CinnagenCompletedAllergic Asthma | Uncontrolled Moderate to SevereIran, Islamic Republic of
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Pain Due to Diabetic PolyneuropathyGermany
-
Ganzhou Hemay Pharmaceutical Co., LtdRecruitingModerate to Severe Ulcerative ColitisChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingModerate to Severe Ulcerative ColitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Ulcerative ColitisUnited States, China, Pakistan, Ukraine
-
Medivation, Inc.PfizerTerminatedModerate to Severe AlzheimerChile, United Kingdom
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
Wenzhou Medical UniversityCompletedEfficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseModerate to Severe Dry Eye SyndromeChina
-
Assistance Publique - Hôpitaux de ParisRecruitingPatients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe TricuspidFrance
-
University of Illinois at ChicagoJohnson & Johnson Vision Care, Inc.UnknownModerate to Severe Dry Eye DiseaseUnited States
-
Chang Gung Memorial HospitalCompletedModerate to Severe COPD Receiving Home Exercise TrainingTaiwan
-
Hyundai Pharmaceutical Co., LTD.RecruitingModerate-to-severe Alzheimer's DiseaseKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterWeizmann Institute of Science; Steba Biotech S.A.Active, not recruitingEsophagogastric Cancer | Moderate to Severe DysphagiaIsrael, United States
-
AstraZenecaCompletedModerate to Severe COPDSweden, Bulgaria, Poland, Denmark, Slovakia
-
Samsung Pharmaceutical Co., Ltd.Not yet recruitingModerate to Severe Alzheimer's Disease
-
King's College LondonUnknownModerate to Severe Alzheimer's DiseaseUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Nantes University HospitalCompletedModerate to Severe Traumatic Brain InjuryFrance